Dealing with pain has become increasingly challenging for columnist Robin Stemple, who struggles to find relief from the hurt ...

New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular dystrophy (DMD). In preclinical DMD mouse models, investigators demonstrated ...

After a decade-long search for answers to her difficulties with walking and other physical activities, Joanne Dalessandro of ...

Muscular Dystrophy UK, the leading charity for more than 110,000 children and adults in the UK living with one of over 60 ...

Alex Harold was diagnosed with Duchenne muscular dystrophy at age four and has long been raising funds for Muscular Dystrophy ...

The one-time treatment is approved for children with a genetic variant of Duchenne’s muscular dystrophy, which causes weakness, loss of mobility and early death in males.

Sarepta Therapeutics said a second patient had died after receiving its $3.2 million gene therapy to treat Duchenne muscular dystrophy.